Accelerate Diagnostics Competitors
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
TMO | Thermo Fisher Scientific | Outperform |
10
|
$595.30 | $591.94 | 4.15% | 1 | $227.24B |
ROG | Roche Holding | Hold |
16
|
CHF237.10 | CHF307.83 | 14.93% | 9 | CHF191.28B |
DHR | Danaher | Outperform |
10
|
$265.80 | $260.33 | 2.49% | 4 | $196.87B |
SIE | Siemens | Outperform |
10
|
172.56€ | 178.14€ | 13.58% | 11 | 135.26€B |
BDX | Becton Dickinson and Co | Outperform |
9
|
$236.30 | $284.47 | 17.44% | 8 | $68.29B |
SHL | Siemens Healthineers | Buy |
8
|
52.88€ | 56.34€ | 13.46% | 9 | 59.00€B |
ILMN | Illumina | Outperform |
16
|
$111.07 | $159.28 | 32.80% | 9 | $17.69B |
HOLX | Hologic | Outperform |
8
|
$75.02 | $81.06 | 12.64% | 3 | $17.51B |
DGX | Quest Diagnostics | Outperform |
10
|
$144.34 | $141.17 | 0.46% | 8 | $16.03B |
BIM | bioMérieux | Outperform |
18
|
95.90€ | 105.55€ | 19.92% | 1 | 11.73€B |
QGEN | QIAGEN N.V. | Outperform |
15
|
$45.69 | $0.00 | 9.43% | 3 | $9.67B |
QDEL | Quidel Corp | Hold |
16
|
$42.82 | $121.00 | 12.10% | 6 | $2.92B |
NEO | NeoGenomics | Outperform |
8
|
$14.80 | $20.09 | 28.38% | 9 | $1.95B |
VCYT | Veracyte | Outperform |
11
|
$22.88 | $32.17 | 31.12% | 4 | $1.61B |
A096530 | Seegene |
18
|
₩22.30k | ₩25.00k | 12.11% | 0 | ₩1.01T | |
CRDF | Cardiff Oncology | Buy |
10
|
$3.63 | $8.37 | 134.16% | 1 | $154.70M |
TTOO | T2 Biosystems | Hold |
6
|
$5.64 | $8.68 | -46.81% | 0 | $31.92M |
BCART | Biocartis Group NV | - |
7
|
0.29€ | 1.10€ | -100.00% | 0 | 27.24€M |
OPGN | OpGen |
2
|
$4.60 | $3.00 | -100.00% | 1 | $5.81M | |
IDXG | Interpace Biosciences | - |
0
|
$1.06 | $11.00 | -100.00% | 0 | $4.54M |
ROSG.Q | Rosetta Genomics | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |